(E/Z)-Rilzabrutinib
Rilzabrutinib (PRN1008) is an orally active Bruton's tyrosine kinase (BTK) inhibitor with anti-inflammatory and immunomodulatory activities. Rilzabrutinib can be used in the research of various inflammatory and immune-related disorders such as acute respiratory distress syndrome and sepsis.
This content will be shared across all product pages.